Literature DB >> 32949730

Exploring the Early Phase of Crohn's Disease.

Giorgos Bamias1, Fabio Cominelli2.   

Abstract

The development of Crohn's disease (CD) is characterized by a breakdown of homeostatic immune-bacterial communication, which takes place at the intestinal mucosa when environmental triggers impact genetically predisposed individuals. Converging lines of evidence support the hypothesis that this pathogenetic model develops through sequential, although inter-related, steps that indicate failure of mucosal defense mechanisms at various stages. In this context, immunologic phenomena that mediate the initial appearance of inflammatory lesions across the intestinal tissue may differ substantially from those that mediate and perpetuate chronic inflammatory responses. A compromise in the integrity of the epithelial barrier is among the earliest events and leads to accelerated influx of intraluminal antigens and intact microorganisms within the immunologically rich lamina propria. Inadequate clearance of invading microorganisms also may occur as a result of defects in innate immunity, preventing the timely and complete resolution of acute inflammatory responses. The final step is the development of persistent adaptive responses, which also differ between early and late Crohn's disease. Current progress in our ability to delineate single-cell transcriptomics and proteomics has allowed the discovery of cellular and molecular mechanisms that participate in each sequential step of CD development. This not only will advance our understanding of CD pathogenesis, but also facilitate the design of targeted therapeutic approaches.
Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adaptive; Crohn's Disease; Cytokines; Early Disease; Epithelium; Innate; Pathogenesis

Mesh:

Year:  2020        PMID: 32949730      PMCID: PMC9217179          DOI: 10.1016/j.cgh.2020.09.023

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  93 in total

1.  Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.

Authors:  M Veny; M Esteller; E Ricart; J M Piqué; J Panés; A Salas
Journal:  Aliment Pharmacol Ther       Date:  2009-12-03       Impact factor: 8.171

2.  Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.

Authors:  G R D'Haens; K Geboes; M Peeters; F Baert; F Penninckx; P Rutgeerts
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

3.  Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment.

Authors:  Christina Eftychi; Robin Schwarzer; Katerina Vlantis; Laurens Wachsmuth; Marijana Basic; Prerana Wagle; Markus F Neurath; Christoph Becker; André Bleich; Manolis Pasparakis
Journal:  Immunity       Date:  2019-07-23       Impact factor: 31.745

4.  Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat.

Authors:  J B Meddings; M G Swain
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

5.  Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.

Authors:  Jochem H Bernink; Lisette Krabbendam; Kristine Germar; Esther de Jong; Konrad Gronke; Michael Kofoed-Nielsen; J Marius Munneke; Mette D Hazenberg; Julien Villaudy; Christianne J Buskens; Willem A Bemelman; Andreas Diefenbach; Bianca Blom; Hergen Spits
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

6.  L-selectin, alpha 4 beta 1, and alpha 4 beta 7 integrins participate in CD4+ T cell recruitment to chronically inflamed small intestine.

Authors:  Jesús Rivera-Nieves; Timothy Olson; Giorgos Bamias; Anthony Bruce; Michael Solga; Robert F Knight; Sharon Hoang; Fabio Cominelli; Klaus Ley
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

7.  Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.

Authors:  P Munkholm; E Langholz; D Hollander; K Thornberg; M Orholm; K D Katz; V Binder
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

8.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Authors:  Lin Deng; Jin-Feng Zhou; Rani S Sellers; Jiu-Feng Li; Andrew V Nguyen; Yubao Wang; Amos Orlofsky; Qiang Liu; David A Hume; Jeffrey W Pollard; Leonard Augenlicht; Elaine Y Lin
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

9.  Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.

Authors:  Christel Rousseaux; Bruno Lefebvre; Laurent Dubuquoy; Philippe Lefebvre; Olivier Romano; Johan Auwerx; Daniel Metzger; Walter Wahli; Béatrice Desvergne; Gian Carlo Naccari; Philippe Chavatte; Amaury Farce; Philippe Bulois; Antoine Cortot; Jean Frédéric Colombel; Pierre Desreumaux
Journal:  J Exp Med       Date:  2005-04-11       Impact factor: 14.307

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.